Showing results (1561-1570 of 1,880) with videos related to

Sort By:
Pageof 188
Nature Cancer|January 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
Nature Medicine|August 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trialKari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Breast Disease|October 9, 2023
Observational analysis of clinical and pathological characteristics and their prognostic impact in Mexican patients with breast cancer: A multi-center studyAnna Gozalishvilli-Boncheva, Iván R Gonzalez-Espinoza, Abraham Castro-Ponce, et al.
Nature Microbiology|January 23, 2020
Author Correction: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillanceXianding Deng, Asmeeta Achari, Scot Federman, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
Nature Microbiology|January 15, 2020
Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillanceXianding Deng, Asmeeta Achari, Scot Federman, et al.
Pageof 188